Prof. Jeffrey Winkler's collaborative research effort with Prof. Ravi K. Amaravadi and colleagues in the Perelman School of Medicine and the Abramson Cancer Center is featured in an early edition of PNAS. The research focuses on development of a potent new drug that clogs up the recycling machinery of tumor cells.
For more information seehttp://www.uphs.upenn.edu/news/News_Releases/2012/05/block/